7-Bromo-3,4-dihydro-2H-1,5-benzodioxepine, 98%, 1g

((2-(2-(2-Bromoethoxy)ethoxy)ethoxy)methyl)benzene, 98%, 5g

(2-Phenoxyphenyl)methanol, 95.0%, 10g

(R)-3-Hydroxypiperidin-2-one, 95+%, 250mg

tert-Butyl (4aS,9bR)-8-fluoro-1,3,4,4a,5,9b-hexahydro-2H-pyrido[4,3-b]indole-2-carboxylate, 95%, 100mg

8-Bromo-2,3-dihydro-1,4-benzodioxine-6-carbaldehyde, 97%, 50mg

(4-(Cyclopropanesulfonamido)phenyl)boronic acid, 95.0%, 100mg

2-Bromo-5-methylthiophene (stabilized with Copper chip + NaHCO3)>98.0%(GC)5g

1,2-dimetoxietano, mínimo 99 %, para síntesis, 500 ml, envase de vidrio

6-Dodecyne>98.0%(GC)5mL

(S)-tert-Butyl (2-oxoazepan-3-yl)carbamate, 97%, 1g

3,6-Dioxa-1,8-octanedithiol>97.0%(GC)500g

METHYL 3-((1,3-DIOXOISOINDOLIN-2-YL)OXY)-2-HYDROXY-2-METHYLPROPANOATE, 90.0%, 1g